Related Experiment Videos
[Anticoagulation in patients with cardiac valve prostheses]
Domenico Paparella1, Chiara d'Agostino, Luigi de Luca Tupputi Schinosa
1Istituto di Cardiochirurgia, Dipartimento d'Emergenza e Trapianti d'Organo, Università, Bari. paparella@tin.it
Recenti Progressi in Medicina
|May 19, 2004
Summary
Patients with artificial heart valves need anticoagulation to prevent blood clots. This guide offers updated recommendations for anticoagulant therapy based on valve type and patient factors, including special situations like pregnancy.
Area of Science:
- Cardiology
- Hematology
- Pharmacology
Context:
- Patients with heart valve prostheses have an elevated risk of thromboembolic events.
- Anticoagulation is frequently necessary post-heart valve replacement surgery.
- Thromboembolic risk is influenced by prosthesis design, patient factors, and anticoagulation effectiveness.
Purpose:
- To review current understanding of thrombus formation pathophysiology.
- To discuss pharmacological properties of common anticoagulants.
- To provide evidence-based suggestions for anticoagulation regimens.
Summary:
- Discusses advances in understanding thrombus formation and anticoagulant pharmacology.
- Offers tailored anticoagulation strategies based on randomized clinical trials, considering prosthesis type, implant site, and patient characteristics.
- Highlights management of complex scenarios like pregnancy and major hemorrhage requiring anticoagulation interruption.
Impact:
- Aims to optimize anticoagulation management in patients with heart valve prostheses.
- Provides guidance for clinicians to reduce thromboembolic events and manage bleeding risks.
- Contributes to improved patient outcomes following heart valve replacement.